Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women.

McGowan I, Cranston RD, Mayer KH, Febo I, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Park SY, Brand RM, Jacobson C, Giguere R, Dolezal C, Frasca T, Leu CS, Schwartz JL, Carballo-Diéguez A.

PLoS One. 2016 Jun 30;11(6):e0158310. doi: 10.1371/journal.pone.0158310. eCollection 2016.

2.

Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection.

Zhang Y, Waterboer T, Pawlita M, Sugar E, Minkoff H, Cranston RD, Wiley D, Burk R, Reddy S, Margolick J, Strickler H, Weber K, Gillison M, D'Souza G.

Cancer Epidemiol. 2016 Aug;43:30-4. doi: 10.1016/j.canep.2016.06.002. Epub 2016 Jun 23.

PMID:
27344614
3.

Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression.

Romas L, Birse K, Mayer KH, Abou M, Westmacott G, Giguere R, Febo I, Cranston RD, Carballo-Diéguez A, McGowan I, Burgener A.

AIDS Res Hum Retroviruses. 2016 Aug 2. [Epub ahead of print]

PMID:
27316778
4.

Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.

Frasca T, Giguere R, Ibitoye M, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A.

Arch Sex Behav. 2016 Apr 29. [Epub ahead of print]

PMID:
27129533
5.

Association of serum cytokines with oral HPV clearance.

Lam JO, Bream JH, Sugar EA, Coles CL, Weber KM, Burk RD, Wiley DJ, Cranston RD, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Guo Y, Xiao W, Gillison ML, D'Souza G.

Cytokine. 2016 Jul;83:85-91. doi: 10.1016/j.cyto.2016.04.002. Epub 2016 Apr 8.

PMID:
27064455
6.

Acceptability of Three Novel HIV Prevention Methods Among Young Male and Transgender Female Sex Workers in Puerto Rico.

Giguere R, Frasca T, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A.

AIDS Behav. 2016 Apr 5. [Epub ahead of print]

PMID:
27048236
7.

To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men.

Bauermeister J, Giguere R, Dolezal C, Leu CS, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A.

AIDS Educ Prev. 2016 Feb;28(1):1-10. doi: 10.1521/aeap.2016.28.1.1.

8.

Anal Cancer Screening in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study.

DʼSouza G, Wentz A, Wiley D, Shah N, Barrington F, Darragh TM, Joste N, Plankey M, Reddy S, Breen EC, Young S, Cranston RD.

J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):570-6. doi: 10.1097/QAI.0000000000000910.

PMID:
26656784
9.

Prevalence of Anal Human Papillomavirus Vaccine Types in the Bangkok Men Who Have Sex With Men Cohort Study.

Cranston RD, Althouse AD, van Griensven F, Janocko L, Curlin ME, Chaikummao S, Chonwattana W, Siegel A, Holtz TH, McGowan I.

Sex Transm Dis. 2015 Dec;42(12):671-6. doi: 10.1097/OLQ.0000000000000372.

PMID:
26562695
10.

Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan.

Dolezal C, Frasca T, Giguere R, Ibitoye M, Cranston RD, Febo I, Mayer KH, McGowan I, Carballo-Diéguez A.

AIDS Educ Prev. 2015 Aug;27(4):289-97. doi: 10.1521/aeap.2015.27.4.289.

11.

The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques.

Janocko L, Althouse AD, Brand RM, Cranston RD, McGowan I.

AIDS Res Hum Retroviruses. 2015 Oct;31(10):981-91. doi: 10.1089/AID.2015.0165. Epub 2015 Aug 24.

PMID:
26214703
12.

Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico.

Giguere R, Dolezal C, Bauermeister JA, Frasca T, Valladares J, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Diéguez A.

J Sex Res. 2016 Jul-Aug;53(6):633-41. doi: 10.1080/00224499.2014.1002127. Epub 2015 Jul 1.

PMID:
26132717
13.

Exploring the feasibility of multi-site flow cytometric processing of gut associated lymphoid tissue with centralized data analysis for multi-site clinical trials.

McGowan I, Anton PA, Elliott J, Cranston RD, Duffill K, Althouse AD, Hawkins KL, De Rosa SC.

PLoS One. 2015 May 26;10(5):e0126454. doi: 10.1371/journal.pone.0126454. eCollection 2015.

14.

High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection.

Beachler DC, Guo Y, Xiao W, Burk RD, Minkoff H, Strickler HD, Cranston RD, Wiley DJ, Jacobson LP, Weber KM, Margolick JB, Sugar EA, Reddy S, Gillison ML, D'Souza G.

J Infect Dis. 2015 Nov 15;212(10):1588-91. doi: 10.1093/infdis/jiv273. Epub 2015 May 7.

PMID:
25954049
15.

Anal human papillomavirus and HIV: A cross-sectional study among men who have sex with men in Moscow, Russia, 2012-2013.

Wirtz AL, Zelaya CE, Peryshkina A, McGowan I, Cranston RD, Latkin C, Galai N, Mogilniy V, Dzhigun P, Kostetskaya I, Beyrer C.

Euro Surveill. 2015 Apr 16;20(15). pii: 21095. Erratum in: Euro Surveill. 2015;20(17). pii: 21110.

16.

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).

Mcgowan I, Cranston RD, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Jacobson C, Rehman KK, Elliott J, Khanukhova E, Abebe K, Mauck C, Spiegel HM, Dezzutti CS, Rohan LC, Marzinke MA, Hiruy H, Hendrix CW, Richardson-Harman N, Anton PA.

PLoS One. 2015 May 5;10(5):e0125363. doi: 10.1371/journal.pone.0125363. eCollection 2015.

17.

Correction: Musosal effects for tenofovir 1% gel.

Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, Dai JY, Cameron MJ, Strobl J, Hughes SM, Hoesley C, Andrew P, Johnson S, Piper J, Friend DR, Ball TB, Cranston RD, Mayer KH, McElrath MJ, McGowan I.

Elife. 2015 Mar 24;4. doi: 10.7554/eLife.07586. No abstract available.

18.

Association between free testosterone levels and anal human papillomavirus types 16/18 infections in a cohort of men who have sex with men.

Hsu HK, Brown TT, Li X, Young S, Cranston RD, D'Souza G, Jacobson LP, Martínez-Maza O, Seaberg EC, Margolick JB, Jenkins FJ, Moran MG, Chua K, Bolan RK, Detels R, Wiley DJ.

PLoS One. 2015 Mar 20;10(3):e0119447. doi: 10.1371/journal.pone.0119447. eCollection 2015.

19.

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, Hendrix CW, Dai JY, Ganesh S, Mkhize B, Taljaard M, Parikh UM, Piper J, Mâsse B, Grossman C, Rooney J, Schwartz JL, Watts H, Marzinke MA, Hillier SL, McGowan IM, Chirenje ZM; VOICE Study Team.

N Engl J Med. 2015 Feb 5;372(6):509-18. doi: 10.1056/NEJMoa1402269.

20.

Mucosal effects of tenofovir 1% gel.

Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, Dai JY, Cameron MJ, Strobl J, Hughes SM, Hoesley C, Andrew P, Johnson S, Piper J, Friend DR, Ball TB, Cranston RD, Mayer KH, McElrath MJ, McGowan I.

Elife. 2015 Feb 3;4. doi: 10.7554/eLife.04525. Erratum in: Elife. 2015;4. doi: 10.7554/eLife.07586.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk